Clene (CLNNW) Long-Term Debt : $7.09 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Clene Long-Term Debt?

Clene's Long-Term Debt for the quarter that ended in Mar. 2024 was $7.09 Mil.

Clene's quarterly Long-Term Debt declined from Sep. 2023 ($16.65 Mil) to Dec. 2023 ($7.15 Mil) and declined from Dec. 2023 ($7.15 Mil) to Mar. 2024 ($7.09 Mil).

Clene's annual Long-Term Debt increased from Dec. 2021 ($19.08 Mil) to Dec. 2022 ($19.25 Mil) but then declined from Dec. 2022 ($19.25 Mil) to Dec. 2023 ($7.15 Mil).

Clene Long-Term Debt Historical Data

The historical data trend for Clene's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene Long-Term Debt Chart

Clene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

0.64

1.95

19.08

19.25

7.15

Clene Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial													16.62	25.84	16.65	7.15	7.09

Clene (NAS:CLNNW) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Clene Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Clene's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Clene (CLNNW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (NAS:CLNNW) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

CLNN:USA 84C:Germany

Address

6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121

Website

https://www.clene.com

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).